Literature DB >> 34855071

Decision thresholds with genetic testing.

Stefan Felder1.   

Abstract

A genetic test is a test for the presence or absence of a genetic mutation. A positive test outcome that reveals a mutation associated with increased risk for a disease may lead a patient to seek preventive treatment provided that the penetrance (probability of developing the disease given the mutation) is sufficiently high. We derive the test threshold and the test-treatment threshold, which confine the mutation probability interval for the use of the genetic test. Test and treatment costs as well as a low penetrance rate of the mutation narrow this interval. We illustrate the model with parameters of the test for BRCA1 and BRCA2 genes as well as of preventive treatment options for breast cancer.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Decision thresholds; Diagnostic risk; Genetic risks; ICER

Mesh:

Year:  2021        PMID: 34855071     DOI: 10.1007/s10198-021-01410-0

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  3 in total

1.  The treatment decision under uncertainty: The effects of health, wealth and the probability of death.

Authors:  Stefan Felder
Journal:  J Health Econ       Date:  2019-11-16       Impact factor: 3.883

2.  The quality of life associated with prophylactic treatments for women with BRCA1/2 mutations.

Authors:  V R Grann; J S Jacobson; V Sundararajan; S M Albert; A B Troxel; A I Neugut
Journal:  Cancer J Sci Am       Date:  1999 Sep-Oct

3.  Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.

Authors:  Gregory F Guzauskas; Shawn Garbett; Zilu Zhou; Scott J Spencer; Hadley S Smith; Jing Hao; Dina Hassen; Susan R Snyder; John A Graves; Josh F Peterson; Marc S Williams; David L Veenstra
Journal:  JAMA Netw Open       Date:  2020-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.